奥马佐单抗
医学
观察研究
不利影响
数据提取
梅德林
荟萃分析
慢性荨麻疹
儿科
内科学
免疫球蛋白E
免疫学
抗体
政治学
法学
作者
Michael D. Tharp,Jonathan A. Bernstein,Abhishek Kavati,Benjamin Ortiz,Karen MacDonald,Kris Denhaerynck,Ivo Abraham,Christopher S. Lee
出处
期刊:JAMA Dermatology
[American Medical Association]
日期:2018-11-14
卷期号:155 (1): 29-29
被引量:140
标识
DOI:10.1001/jamadermatol.2018.3447
摘要
Benefits and safety of omalizumab in the real-world treatment of CIU meet or exceed results gleaned from clinical trials. These real-world data on omalizumab in CIU may help inform both clinical treatment expectations and policy decision making.
科研通智能强力驱动
Strongly Powered by AbleSci AI